Drug profile · INN
conestat alfa
RUCONEST
conestat alfa (RUCONEST) is a plasma protease c1 inhibitor exogenous protein.
EMA: approved Blood and blood forming organs (B06) B06AC04
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — conestat alfa
- Class
- Blood and blood forming organs (B06)
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
conestat alfa (RUCONEST) is a plasma protease c1 inhibitor exogenous protein.
Key facts
INN conestat alfa
Brand RUCONEST
Mechanism Plasma protease C1 inhibitor exogenous protein
Target Plasma protease C1 inhibitor
Therapeutic class Blood and blood forming organs (B06)
ATC code B06AC04
Mechanism of action
Plasma protease C1 inhibitor exogenous protein
Primary target: Plasma protease C1 inhibitor
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Related & competitor drugs
Frequently asked questions
What is conestat alfa?
conestat alfa (RUCONEST) is a plasma protease c1 inhibitor exogenous protein.
What is the brand name for conestat alfa?
RUCONEST is a marketed brand name for conestat alfa. Check FDA Drugs@FDA for the current US label holder and prescribing information.